← Leaderboards
Robert L. Matts
Oklahoma State University Stillwater
$1,316,232
Attributed
$1,608,278
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $438.1K · FY2007–17$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,608,278 · 3
By mechanism
R01$1,170,209 · 2
R15$438,069 · 1
Top collaborators
- Junpeng Deng1 shared
- Steven D Hartson1 shared
Most similar at Oklahoma State University Stillwater
Same institution · by research overlap
- Steven D Hartson$571,764
- Junpeng Deng$4,147,664
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCancer Cell LineMalignant NeoplasmsProtein FoldingMolecular ChaperonesCancer TherapyInhibitor/AntagonistIn VivoClinical TrialsOncogenicStructure-Activity RelationshipCombinatorialC-TerminalBaseAffinityFamilyInsightChaperone MachineryBiochemicalAntioxidantsBinding (Molecular Function)AffectCurcuminCytotoxicity
Grant awards (7)
Structure/Function Studies of Anti-cancer Hsp90 Inhibitors that Target the C-terminal Domain$438,069
R15 · FY2017 · CA · contact PI
Identification of Natural Product Inhibitors of Hsp90 as Chemotherapeutic Agents$203,654
R01 · FY2010 · CA · contact PI
Identification of Natural Product Inhibitors of Hsp90 as Chemotherapeutic Agents$203,654
R01 · FY2009 · CA · contact PI
Identification of Natural Product Inhibitors of Hsp90 as Chemotherapeutic Agents$104,360
R01 · FY2009 · CA · contact PI
Identification of Natural Product Inhibitors of Hsp90 as Chemotherapeutic Agents$221,287
R01 · FY2008 · CA · contact PI
Identification of Natural Product Inhibitors of Hsp90 as Chemotherapeutic Agents$260,703
R01 · FY2007 · CA · contact PI
LCK TYROSINE KINASE/HEAT SHOCK PROTEIN INTERACTION$176,551
R01 · FY2000 · GM